This site requires JavaScript and cookies to be enabled.

ADHD in women and men

While gender can’t completely predict someone’s ADHD journey, there can be differences in how women and men present their ADHD symptoms, and their age of diagnosis.

ADHD in women  

ADHD in men  

Women with ADHD are more likely to:


  • Experience symptoms of inattentive ADHD, which can be less obvious than hyperactive and impulsive symptoms. These include being disorganized, distracted, overwhelmed, or trouble initiating tasks
  • Mask or overcompensate for their symptoms, leading to a delayed diagnosis
  • Get diagnosed in adulthood, despite having dealt with ADHD symptoms since childhood. In fact, most women with ADHD don’t receive an accurate diagnosis until their late 30s or early 40s
  • Experience fluctuations in the severity of their ADHD symptoms over the course of their hormone cycles

Did you know? The percentage of women newly diagnosed with ADHD between 23-29 and 30-49 years of age nearly doubled in just two years, from 2020 to 2022

Women with ADHD are more likely to be called out for:

  • being overwhelmed
  • being chronically disorganized
  • exhibiting poor time management/chronic lateness
  • experiencing low self-esteem
  • being unable to manage daily activities/chores
  • finding making/keeping friendships difficult

Research now points to the fact that the prevalence of ADHD in adult women is significant. And we are in need of better training and tools to diagnose and support treatment.

Are you a new mother or mother-to-be with ADHD?

Learn about Qelbree and lactation 

ADHD in women  

ADHD in men  

Men with ADHD are more likely to:


  • Experience symptoms of hyperactive and impulsive ADHD
  • Get diagnosed in childhood, as they’re more likely to act out in the classroom or at home
  • Engage in “externalizing” behavior, or hyperactive/impulsive behaviors directed outwardly towards other people or one’s environment

Men with ADHD are more likely to be called out for:

  • sloppiness
  • careless mistakes
  • trouble listening
  • forgetting appointments
  • procrastination
  • restlessness
  • disorganization
  • misplacing things constantly
  • excessive talking
  • inability to contain frustration

Both men’s and women’s ADHD experiences are challenging and valid. But if we’re to close this diagnosis gap, knowing how they may differ is key. Luckily, as ADHD awareness continues to rise, so do the number of women getting diagnosed and treated.

What is Qelbree?

Qelbree is the first non-stimulant approved for adult ADHD in over 20 years.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.